statistiche ricercatore

Continente	#
EU - Europa	757
NA - Nord America	405
AS - Asia	288
SA - Sud America	27
Continente sconosciuto - Info sul continente non disponibili	19
AF - Africa	9
OC - Oceania	1
Totale	1.506

Nazione	#
RU - Federazione Russa	510
US - Stati Uniti d'America	392
IT - Italia	109
SG - Singapore	106
IE - Irlanda	58
HK - Hong Kong	54
CN - Cina	39
DE - Germania	30
VN - Vietnam	29
BR - Brasile	21
KR - Corea	16
FI - Finlandia	10
IN - India	10
JP - Giappone	10
NL - Olanda	10
BD - Bangladesh	9
FR - Francia	6
CA - Canada	5
IL - Israele	5
PL - Polonia	5
AR - Argentina	4
AT - Austria	4
MX - Messico	4
GB - Regno Unito	3
SC - Seychelles	3
AE - Emirati Arabi Uniti	2
ES - Italia	2
HU - Ungheria	2
TH - Thailandia	2
AM - Armenia	1
AZ - Azerbaigian	1
BN - Brunei Darussalam	1
BW - Botswana	1
CH - Svizzera	1
CO - Colombia	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
EC - Ecuador	1
HN - Honduras	1
HR - Croazia	1
IS - Islanda	1
KE - Kenya	1
KZ - Kazakistan	1
LC - Santa Lucia	1
LV - Lettonia	1
MA - Marocco	1
NZ - Nuova Zelanda	1
PA - Panama	1
PT - Portogallo	1
SE - Svezia	1
SV - El Salvador	1
SY - Repubblica araba siriana	1
TN - Tunisia	1
TR - Turchia	1
UA - Ucraina	1
XK - ???statistics.table.value.countryCode.XK???	1
ZA - Sudafrica	1
Totale	1.488

Nome	#
The use of ultrasound in the evaluation of postoperative pneumothorax and lung re-expansion in patients after lung resection	211
A trimodality, four-step treatment including chemotherapy, pleurectomy/decortication and radiotherapy in early-stage malignant pleural mesothelioma: A single-institution retrospective case series study	202
Immunotherapy for head and neck cancer: Present and future	186
Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial	179
Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial	161
Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis	156
Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy	150
Translational insights and new therapeutic perspectives in head and neck tumors	136
Unleashing precision: A review of targeted approaches in pleural mesothelioma	125
Totale	1.506

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	28	0	0	0	0	0	1	2	6	1	2	8	8
2022/2023	138	8	4	3	18	24	11	1	7	57	1	2	2
2023/2024	71	7	10	3	1	13	14	3	4	2	0	7	7
2024/2025	234	4	16	0	2	31	24	28	22	47	22	20	18
2025/2026	875	36	41	33	22	83	461	38	46	31	24	42	18
2026/2027	160	5	19	31	84	21	0	0	0	0	0	0	0
Totale													1.506